Drug Profile
PF 886
Latest Information Update: 13 Nov 1995
Price :
$50
*
At a glance
- Originator Almirall-Prodesfarma
- Class Antihypertensives; Antiplatelets; Bronchodilators; Heart failure therapies
- Mechanism of Action Diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 13 Nov 1995 Discontinued-Preclinical for Hypertension in Spain (Unknown route)
- 09 Nov 1995 New profile